
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| KONVOMEP | Azurity | N-213593 RX | 2022-08-30 | 1 products, RLD, RS |
| ZEGERID OTC | Riley Consumer Care Holdings | N-022281 OTC | 2009-12-01 | 1 products, RLD, RS |
| ZEGERID OTC | Riley Consumer Care Holdings | N-022283 OTC | 2013-06-17 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| OMEPRAZOLE | Dexcel Pharma | N-209400 OTC | 2017-07-05 | 1 products, RLD, RS |
| OMEPRAZOLE | Dexcel Pharma | N-022032 OTC | 2007-12-04 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| YOSPRALA | Genus Lifesciences | N-205103 DISCN | 2016-09-14 | 2 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| OMECLAMOX-PAK | Cumberland Pharmaceuticals | N-050824 DISCN | 2011-02-08 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| TALICIA | RedHill Biopharma | N-213004 RX | 2019-11-01 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| PRILOSEC OTC | AstraZeneca | N-021229 OTC | 2003-06-20 | 1 products, RLD, RS |
| PRILOSEC | Covis Pharma | N-022056 RX | 2008-03-20 | 2 products, RLD, RS |
Brand Name | Status | Last Update |
|---|---|---|
| 24 hr omeprazole | New Drug Application | 2025-01-14 |
| acid reducer | ANDA | 2025-07-23 |
| acid reducer powder | ANDA | 2025-03-03 |
| amazon basic care omeprazole | ANDA | 2024-05-10 |
| aspirin and omeprazole delayed-release tab | New Drug Application | 2019-11-20 |
| basic care omeprazole | New Drug Application | 2025-09-22 |
| basic care omeprazole and sodium bicarbonate | ANDA | 2021-07-22 |
| berkley and jensen omeprazole | New Drug Application | 2025-03-06 |
| care one omeprazole | New Drug Application | 2025-02-06 |
| careone omeprazole | New Drug Application | 2025-04-17 |
Expiration | Code | ||
|---|---|---|---|
AMOXICILLIN / OMEPRAZOLE MAGNESIUM / RIFABUTIN, TALICIA, REDHILL | |||
| 2027-11-01 | GAIN | ||
| 2022-11-01 | NP | ||
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Amoxicillin / Omeprazole Magnesium / Rifabutin, Talicia, Redhill | |||
| 11878011 | 2042-05-27 | U-3816 | |
| 9050263 | 2034-02-12 | DP | U-2660 |
| 9498445 | 2034-02-12 | DP | U-2660 |
| 9603806 | 2034-02-12 | DP | U-2660 |
| 10238606 | 2034-02-12 | DP | |
| 11135172 | 2034-02-12 | DP | U-2660 |
| Omeprazole / Sodium Bicarbonate, Konvomep, Azurity | |||
| 11771686 | 2040-03-01 | U-623 | |
| 10751333 | 2039-07-16 | DP | |
| 11103492 | 2039-07-16 | DP | |
| 11633478 | 2039-07-16 | DP | |
| Omeprazole, Omeprazole, Dexcel | |||
| 10076494 | 2036-12-08 | DP | |
| 10835488 | 2036-12-08 | DP | |
| Aspirin / Omeprazole, Yosprala, Genus Lifesciences | |||
| 9539214 | 2033-03-13 | U-1902 | |
| 9987231 | 2033-01-02 | U-2324 | |
| Omeprazole, Omeprazole, Dexcel Pharma | |||
| 9023391 | 2025-08-16 | DP | |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 164 | 1 | 1 | 9 | 6 | 180 |
| Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | 17 | 24 | 41 | 52 | 36 | 164 |
| Infections | D007239 | EFO_0000544 | — | 11 | 9 | 16 | 68 | 30 | 127 |
| Helicobacter infections | D016481 | EFO_1000961 | — | 2 | 4 | 13 | 29 | 19 | 66 |
| Ulcer | D014456 | MPATH_579 | — | 5 | 6 | 24 | 15 | 7 | 56 |
| Peptic esophagitis | D004942 | EFO_1001095 | — | 3 | 5 | 17 | 10 | 11 | 45 |
| Esophagitis | D004941 | HP_0100633 | K20 | 4 | 5 | 15 | 11 | 9 | 43 |
| Peptic ulcer | D010437 | — | K27 | 4 | 3 | 9 | 22 | 5 | 43 |
| Dyspepsia | D004415 | EFO_0008533 | K30 | 4 | 7 | 9 | 18 | 6 | 42 |
| Communicable diseases | D003141 | — | — | 4 | 3 | 5 | 18 | 11 | 39 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 6 | 2 | 2 | — | 1 | 10 |
| Recurrence | D012008 | — | — | 1 | 1 | 2 | — | 1 | 4 |
| Gastrinoma | D015408 | — | — | — | 1 | 1 | — | 1 | 3 |
| Zollinger-ellison syndrome | D015043 | — | E16.4 | — | 1 | 1 | — | 1 | 3 |
| Pancreatitis | D010195 | EFO_0000278 | K85 | 1 | — | 1 | — | 1 | 3 |
| Asthma | D001249 | EFO_0000270 | J45 | — | 2 | 1 | — | — | 3 |
| Human experimentation | D006805 | — | — | — | — | 3 | — | — | 3 |
| Squamous cell carcinoma | D002294 | — | — | — | 2 | 1 | — | — | 3 |
| Exocrine pancreatic insufficiency | D010188 | — | K86.81 | — | 1 | 1 | — | 1 | 3 |
| Granuloma | D006099 | — | — | — | 1 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 21 | 2 | — | — | — | 23 |
| Lymphoma | D008223 | — | C85.9 | 3 | 3 | — | — | 2 | 8 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 4 | 3 | — | — | 1 | 8 |
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | 1 | 7 | — | — | — | 7 |
| Fatty liver | D005234 | EFO_0003934 | — | 1 | 7 | — | — | — | 7 |
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | 1 | 6 | — | — | — | 6 |
| Dermatitis | D003872 | — | L30.9 | 4 | 2 | — | — | — | 6 |
| Hepatitis c | D006526 | — | B19.2 | 5 | 1 | — | — | — | 6 |
| Atopic dermatitis | D003876 | EFO_0000274 | L20 | 4 | 1 | — | — | — | 5 |
| B-cell lymphoma marginal zone | D018442 | — | C88.4 | 1 | 2 | — | — | 2 | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pharmacokinetics | D010599 | — | — | 7 | — | — | — | — | 7 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 6 | — | — | — | — | 6 |
| Drug-related side effects and adverse reactions | D064420 | — | T88.7 | 1 | — | — | — | 3 | 4 |
| Covid-19 | D000086382 | — | U07.1 | 1 | — | — | — | 3 | 4 |
| Therapeutic equivalency | D013810 | — | — | 3 | — | — | — | — | 3 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 3 | — | — | — | — | 3 |
| Chronic hepatitis b | D019694 | EFO_0004239 | B18.1 | 3 | — | — | — | — | 3 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | 3 | — | — | — | — | 3 |
| Melanoma | D008545 | — | — | 2 | — | — | — | — | 2 |
| Sickle cell anemia | D000755 | EFO_0000697 | D57 | 2 | — | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | — | — | 2 | 2 |
| Vasovagal syncope | D019462 | — | R55 | — | — | — | — | 2 | 2 |
| Syncope | D013575 | — | G90.01 | — | — | — | — | 2 | 2 |
| Major depressive disorder | D003865 | EFO_0003761 | F22 | — | — | — | — | 1 | 1 |
| Depressive disorder | D003866 | EFO_1002014 | F32.A | — | — | — | — | 1 | 1 |
| Pneumonia | D011014 | EFO_0003106 | J18 | — | — | — | — | 1 | 1 |
| Community-acquired pneumonia | D000098968 | — | — | — | — | — | — | 1 | 1 |
| Iga vasculitis | D011695 | EFO_1000965 | D69.0 | — | — | — | — | 1 | 1 |
| Pyloromyotomy | D000074882 | — | — | — | — | — | — | 1 | 1 |
| Peripheral arterial disease | D058729 | EFO_0004265 | — | — | — | — | — | 1 | 1 |
| Drug common name | Omeprazole |
| INN | omeprazole |
| Description | 6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole is a member of benzimidazoles and a sulfoxide. |
| Classification | Small molecule |
| Drug class | antiulcer agents (benzimidazole derivatives) |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1 |
| PDB | — |
| CAS-ID | 73590-58-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1503 |
| ChEBI ID | 77260 |
| PubChem CID | 4594 |
| DrugBank | DB00338 |
| UNII ID | KG60484QX9 (ChemIDplus, GSRS) |













